Telehealth

Neurocrine Biosciences begins a Phase 2 trial for a new tardive dyskinesia drug, aiming to build on its market dominance and offer new hope for patients.

Aja Health inks a deal with Greatway Financial to sell its MyCare Ally program and upgrades its GOeVisit platform for advanced virtual care services.

A new strategic partnership aims to dismantle commercialization hurdles, promising faster access to life-saving therapies for rare disease patients.

The baby registry giant is moving into original audio, launching a new podcast to counter online misinformation and empower parents through childbirth.

As providers face growing financial risk and complex rules, Roji's 19-year CMS certification highlights the critical role of trusted data partners.

U.S. firm Catheter Precision secures its first German order for the LockeT device, a strategic move into Europe's largest and most innovative healthcare market.

Swedish biotech innovator Hansa Biopharma wins a top award for its life-saving transplant tech, facing a pivotal year with FDA review on the horizon.

Canada aims to eliminate cervical cancer by 2040, but rising rates and lagging prevention efforts place the ambitious public health goal at a crossroads.

Amid explosive growth, GMVA hires a new CFO to manage its expansion and lead the financial strategy for its upcoming Agentic AI healthcare platform.

A new partnership offers a free AI-powered oral scan to identify dental issues in kids, aiming to connect underserved families to much-needed care.

Amid rising threats, the U.S. Health Department is investing in intelligence-driven cybersecurity to protect critical health systems and patient data.

As the U.S. faces a maternal care crisis, Ob Hospitalist Group brings in new financial and growth chiefs to scale its solutions for hospitals nationwide.

Ascletis Pharma unveils ASC37, a next-gen, once-monthly obesity drug claiming superior potency and convenience, challenging giants like Eli Lilly.

Advocates warn that systemic delays under Jordan's Principle are denying First Nations and Inuit children the essential healthcare they are legally owed.

Midwest retailer Meijer partners with WellSync to offer $29.99 virtual care visits with no insurance, challenging competitors like CVS and Walmart.

The Canadian fertility network appoints former CFO Heather Stark as its first female CEO, signaling a strategic shift toward operational excellence and growth.

A novel cell therapy for Parkinson's earns a key FDA designation, signaling a potential paradigm shift from managing symptoms to reversing the disease.

Carrying the Alzheimer's gene, a longevity expert has turned himself into a public experiment, documenting his radical protocol to prevent the disease.

Equinox's new EQX ARC program partners with Oura and Function to offer hyper-personalized, data-driven training for women across all life stages.

Kaiser Permanente hires veteran strategist Beth Leonard for a new C-suite role, signaling a major push to influence policy and export its care model.